Brain-derived neurotrophic factor and TrkB expression in the “oldest-old,” the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Factors associated with maintaining good cognition into old age are unclear. Decreased brain-derived neurotrophic factor (BDNF) contributes to memory loss in Alzheimer's disease (AD), and soluble assemblies of amyloid-beta (Aβ) and tau contribute to neurodegeneration. However, it is unknown whether AD-type neuropathology, soluble Aβ and tau, or levels of BDNF and its receptor TrkB correlate with dementia in the oldest-old. We examined these targets in post-mortem Brodmann's areas 7 and 9 (BA7, BA9) in 4 groups of subjects >90 years old: 1) No Dementia/No AD Pathology, 2) No Dementia/AD Pathology, 3) Dementia/No AD Pathology, 4) Dementia/AD Pathology. In BA7, BDNF mRNA correlated with MMSE scores and was decreased in demented vs. non-demented subjects, regardless of pathology. Soluble Aβ42 was increased in both groups with AD pathology, demented or not, compared to No dementia/No AD Pathology subjects. Groups did not differ in TrkB isoform levels or in levels of total soluble tau, individual tau isoforms, threonine-181 tau phosphorylation or ratio of phosphorylated 3R to 4R isoforms. In BA9, soluble Aβ42 correlated with MMSE scores and with BDNF mRNA expression. Thus, soluble Aβ42 and BDNF, but not TrkB or soluble tau, correlate with dementia in the oldest-old.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 4×
“Protein extraction and measurements Extraction of soluble Aβ was based on previously published methods with some modifications (Steinerman, 2008; Lesné et al., 2006; Kawarabayashi et al., 2001).”
BackgroundMethodInfluentialRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · cited 2×
“Tau protein contains multiple putative serine (Ser), threonine (Thr), and tyrosine phosphorylation sites which are phosphorylated in both normal and fibrillar tau (reviewed in Buée et al., 2000; Lee et al., 2001).”
BackgroundSynapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 2×
“We also examined some of these targets and correlations in prefrontal cortex (Brodmann area 9), another area severely affected in AD (DeKosky and Scheff, 1990).”
BackgroundThe toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962 · cited 2×
“Soluble Aβ42 has emerged as a potentially toxic molecule, explaining why insoluble, fibrillar Aβ42 plaques often do not correlate well with cognitive decline in AD subjects (Benilova et al., 2012).”
BackgroundGoedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · cited 2×
“Tau is a natively unfolded, highly soluble, microtubuleassociated protein that exists in brain in 6 different isoforms (Goedert et al., 1988; Lewis et al., 1988).”
BackgroundGong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · cited 2×
“This disagreement led to the emerging idea that AD-type dementia might be caused not by plaques but rather by different pools and assemblies of soluble Ab (Gong et al., 2003; Kuo et al., 1996; Lesné et al., 2006; McDonald et al., 2010; Steinerman et al., 2008).”
BackgroundKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 1×
“Protein extraction and measurements Extraction of soluble Aβ was based on previously published methods with some modifications (Steinerman, 2008; Lesné et al., 2006; Kawarabayashi et al., 2001).”
MethodBDNF and synaptic plasticity, cognitive function, and dysfunction
Lu, B., Nagappan, G., & Lu, Y. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_9 · Cited by 1,043 · cited 2×
“BDNF is vital for learning and memory (Lu et al., 2014; Yamada and Nabeshima, 2003).”
BackgroundNagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · cited 2×
“Restoring BDNF levels in animal models of AD by delivery of protein, viral vectors, or stem cells (Blurton-Jones et al., 2009; Nagahara et al., 2009) or by lifestyle changes such as antioxidant diet and environmental enrichment (physical and cognitive exercise and social interaction; Fahnestock et al.”
BackgroundGoedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929 · cited 8×
“The isoforms are differentially expressed during development and are differentially distributed (Goedert and Jakes, 1990; Kosik et al., 1989), which suggests they have different physiological roles.”
BackgroundInfluentialAge, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900 · cited 1×
“There are reports of a lack of association between dementia and pathology in this population (Haroutunian et al., 2008; Savva et al., 2009) as well as studies reporting strong correlations of Aβ and tau pathologies with dementia (Gold et al., 2000; Nelson et al., 2007; Dolan et al., 2010).”
BackgroundMurer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · cited 1×
“There is substantial evidence suggesting that neurotrophic factors, mainly BDNF, play an important role in the etiology of AD (Fahnestock, 2011; Siegel et al., 2000; Murer et al., 2001).”
BackgroundStaging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · cited 2×
“Despite a relatively well-documented association between the amount of AD-type neuropathology and the severity of cognitive impairment (Arriagada et al., 1992; Bennett et al., 2004; Berg et al., 1998; Braak et al., 1993; Gold et al., 2000; Nagy et al., 1995), there is a lack of agreement regarding the contribution of…”
BackgroundPeng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03135.x · Cited by 691
Self-citationBerg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657 · cited 2×
“Despite a relatively well-documented association between the amount of AD-type neuropathology and the severity of cognitive impairment (Arriagada et al., 1992; Bennett et al., 2004; Berg et al., 1998; Braak et al., 1993; Gold et al., 2000; Nagy et al., 1995), there is a lack of agreement regarding the contribution of…”
BackgroundWater-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618 · cited 1×
“This disagreement led to the emerging idea that AD-type dementia might be caused not by plaques, but rather by different pools and assemblies of soluble Aβ (Kuo et al., 1996; Gong et al., 2003; Lesné et al., 2006; McDonald et al., 2010; Steinerman et al., 2008).”
BackgroundBrain-derived neurotrophic factor is reduced in Alzheimer's disease
Connor, B., Young, D., Yan, Q., Faull, R. L. M., Synek, B., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00125-3 · Cited by 581
Bennett, D. A., Schneider, J. A., Wilson, R. S., Bienias, J. L., & Arnold, S. E. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.378 · Cited by 526 · cited 2×
“Despite a relatively well-documented association between the amount of AD-type neuropathology and the severity of cognitive impairment (Arriagada et al., 1992; Bennett et al., 2004; Berg et al., 1998; Braak et al., 1993; Gold et al., 2000; Nagy et al., 1995), there is a lack of agreement regarding the contribution of…”
BackgroundHock, C., Heese, K., Hulette, C., Rosenberg, C., & Otten, U. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.846 · Cited by 523 · cited 2×
“Most studies on younger-old subjects (mainly in their 70s and 80s) have demonstrated that areas of the brain predominantly affected by AD-type pathology, hippocampus, cortex, and basal forebrain, exhibit downregulated levels of BDNF (Connor et al., 1997; Ferrer et al., 1999; Garzon et al., 2002; Hock et al., 2000; Hol…”
BackgroundMultiple pathologies are common and related to dementia in the oldest-old: The 90+ Study
Kawas, C. H., Kim, R. C., Sonnen, J. A., Bullain, S. S., Trieu, T., & Corrada, M. M. (2015) · Neurology · doi:10.1212/wnl.0000000000001831 · Cited by 303 · cited 1×
“For a more complete description of 90+ Study procedures, see Corrada et al. (2012) and Kawas et al. (2015).”
BackgroundSelf-citationNelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292 · cited 4×
“, 2009) aswell as studies reporting strong correlations of Ab and tau pathologies with dementia (Dolan et al., 2010; Gold et al., 2000; Nelson et al., 2007).”
BackgroundInfluentialTau isoform regulation is region‐ and cell‐specific in mouse brain
McMillan, P., Korvatska, E., Poorkaj, P., Evstafjeva, Z., Robinson, L., Greenup, L., Leverenz, J., Schellenberg, G. D., & D'Souza, I. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21867 · Cited by 179 · cited 2×
“Regulation of tau isoform expression is region and cell-specific (Ginsberg et al., 2006a; McMillan et al., 2008) which might explain discrepancies between ours and Ginsberg et al. (2006a) results.”
ResultA Population-Based Clinicopathological Study in the Oldest-Old: The 90+ Study
M. Corrada, M., J. Berlau, D., & H. Kawas, C. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322537 · Cited by 162 · cited 1×
“For a more complete description of 90+ Study procedures, see Corrada et al. (2012) and Kawas et al. (2015).”
BackgroundRobinson, J. L., Molina-Porcel, L., Corrada, M. M., Raible, K., Lee, E. B., Lee, V. M.-Y., Kawas, C. H., & Trojanowski, J. Q. (2014) · Brain · doi:10.1093/brain/awu190 · Cited by 157
Self-citationRole of the neuropathology of Alzheimer disease in dementia in the oldest-old
Haroutunian, V., Schnaider-Beeri, M., Schmeidler, J., Wysocki, M., Purohit, D. P., Perl, D. P., Libow, L. S., Lesser, G. T., Maroukian, M., & Grossman, H. T. (2008) · Archives of Neurology · doi:10.1001/archneur.65.9.1211 · Cited by 154
Clinical validity of Braak neuropathological staging in the oldest-old
Gold, G., Bouras, C., Kövari, E., Canuto, A., González Glaría, B., Malky, A., Hof, P. R., Michel, J.-P., & Giannakopoulos, P. (2000) · Acta Neuropathologica · doi:10.1007/s004010051163 · Cited by 128 · cited 4×
“…neuropathology and the severity of cognitive impairment (Arriagada et al., 1992; Bennett et al., 2004; Berg et al., 1998; Braak et al., 1993; Gold et al., 2000; Nagy et al., 1995), there is a lack of agreement regarding the contribution of amyloid plaques and neurofibrillary tangles towards…”
BackgroundInfluentialGinsberg, S. D., Che, S., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03641.x · Cited by 111 · cited 3×
“Whether the ratio of 4R/3R isoforms is altered in AD is controversial (Hong et al., 1998; Ginsberg et al., 2006a).”
BackgroundResultDistinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain: A Clinicopathologic Study
Steinerman, J. R., Irizarry, M., Scarmeas, N., Raju, S., Brandt, J., Albert, M., Blacker, D., Hyman, B., & Stern, Y. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.906 · Cited by 104 · cited 2×
“This disagreement led to the emerging idea that AD-type dementia might be caused not by plaques but rather by different pools and assemblies of soluble Ab (Gong et al., 2003; Kuo et al., 1996; Lesné et al., 2006; McDonald et al., 2010; Steinerman et al., 2008).”
BackgroundNeocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old
Robinson, J. L., Geser, F., Corrada, M. M., Berlau, D. J., Arnold, S. E., Lee, V. M.-Y., Kawas, C. H., & Trojanowski, J. Q. (2011) · Brain · doi:10.1093/brain/awr308 · Cited by 88
Self-citationAlzheimer's Disease: The Downside of a Highly Evolved Parietal Lobe?
Bruner, E., & Jacobs, H. I. L. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122299 · Cited by 87 · cited 2×
“…because it is an area of parietal cortex that we have previously studied intensively for its BDNF expression and regulation (Holsinger et al., 2000; Garzon et al., 2002; Michalski & Fahnestock, 2003; Peng et al., 2005), and it is an area known to be severely affected in AD (Bruner & Jacobs, 2013).”
BackgroundAge, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing
Dolan, D., Troncoso, J., Resnick, S. M., Crain, B. J., Zonderman, A. B., & O'Brien, R. J. (2010) · Brain · doi:10.1093/brain/awq141 · Cited by 70
Cited by
The Gut Microbiota and Alzheimer’s Disease
Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540
The links between the gut microbiome, aging, modern lifestyle and Alzheimer's disease
Askarova, S., Umbayev, B., Masoud, A.-R., Kaiyrlykyzy, A., Safarova, Y., Tsoy, A., Olzhayev, F., & Kushugulova, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00104 · Cited by 208
Tejeda, G., & Díaz-Guerra, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020268 · Cited by 126
Metadata
- Authors
- Michalski, B., Corrada, M. M., Kawas, C. H., & Fahnestock, M.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 36
- Issue
- 12
- Pages
- 3130-3139
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2155448933
- Cited by
- 56
- References
- 34
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.